News Focus
News Focus
Followers 10
Posts 1716
Boards Moderated 0
Alias Born 04/15/2013

Re: FeMike post# 727980

Wednesday, 10/23/2024 1:46:12 PM

Wednesday, October 23, 2024 1:46:12 PM

Post# of 828264
FeMike, to my knowledge, most patients or their families don’t make decisions independently, they may seek a second opinion to verify what their doctor has identified. Generally, they tend to follow their doctor’s advice instead of relying solely on their own research, mainly because of fear. If they stray from their doctor’s recommendations, they might hesitate to return to that same doctor. Many in the older generation distrust information from Google and believe that doctors provide more reliable guidance. Even when patients bring up their online research, doctors may suggest different treatment options, which ultimately places the decision-making in their hands. As a result, most patients and their families prefer to trust their doctors’ recommendations, and it’s usually the doctor who determines the appropriate treatment plan. If DCVAX-L is approved by the MHRA and becomes public news, it will likely gain significant attention, and most doctors will make decisions based on approved treatments.


DCVax-L has been available as a treatment, commercially, in the UK for over a year now.

Why aren't GBM patients flooding in from all around the globe to receive treatment? Why isn't NWBO reporting sold out manufacturing revenue? You think just because it isn't approved, potential patients don't know about it?

If you get diagnosed with GBM, the first thing you are doing is googling for trials and treatment options. The average Joe doesn't have a clue what DCVax is, but it isn't hard to find if you're looking for it with purpose.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News